[{"ID":"EL000014", "Name":"CCAT2", "NCBI_gene_Id":"101805488", "Aliases":"colon cancer associated transcript 2;NCCP1; LINC00873", "Reason":"Knockdown of long non coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/\u03b2 catenin pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that is upregulated in colon cancer and other cancers. This transcript promotes cell proliferation and suppresses apoptosis. It negatively regulates the biogenesis of microRNA 145.", "PMID":"33125134", "fId":14, "NONCODEId":"NONHSAG099120.1"},
 {"ID":"EL000020", "Name":"TUG1", "NCBI_gene_Id":"55000", "Aliases":"taurine upregulated gene 1;TI-227H; LINC00080; NCRNA00080", "Reason":"knockdown of TUG1 could impair HCC cells proliferation, invasion and induce cell apoptosis both in vitro and vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"Involved in photoreceptor cell development and regulation of gene expression. Localizes to nucleus. Is expressed in several structures, including central nervous system; heart; olfactory epithelium; retina; and spleen. Orthologous to human TUG1 (taurine up-regulated 1).", "PMID":"26336870", "fId":20, "NONCODEId":"NONHSAG033691.3"},
 {"ID":"EL000038", "Name":"HOTTIP", "NCBI_gene_Id":"100316868", "Aliases":"HOXA distal transcript antisense RNA;HOXA-AS6; HOXA13-AS1; NCRNA00213", "Reason":"LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long RNA in antisense to the HOXA gene cluster. This transcript may regulate expression of HOXA genes in cis. This gene is upregulated in tumors and is implicated in the promotion of cell proliferation.", "PMID":"33000231", "fId":38, "NONCODEId":"NONHSAG047197.2"},
 {"ID":"EL000041", "Name":"HULC", "NCBI_gene_Id":"728655", "Aliases":"hepatocellular carcinoma up-regulated long non-coding RNA;HCCAT1, LINC00078, NCRNA00078", "Reason":"Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long RNA that was discovered as upregulated in hepatocellular carcinoma and is associated with cancer progression. Expression of this transcript is regulated by microRNAs and at the transcriptional level by Sp1 family factors. The transcript may regulate gene expression by functioning as a competing RNA for microRNAs.", "PMID":"30551459", "fId":41, "NONCODEId":"NONHSAG042970.2"},
 {"ID":"EL000042", "Name":"CYTOR", "NCBI_gene_Id":"112597", "Aliases":"cytoskeleton regulator RNA;C2orf59; LINC00152; NCRNA00152", "Reason":"Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that is overexpressed in cancer cells and promotes cell proliferation and epithelial-mesenchymal transition. This RNA may bind enhancer of zeste homolog 2 and participate in the transcriptional silencing of tumor suppressor genes. It may act as a sponge for microRNAs. Alternatively spliced variants have been observed.", "PMID":"29669323", "fId":42, "NONCODEId":"NONHSAG077527.2"},
 {"ID":"EL000043", "Name":"LNCRNA-ATB", "NCBI_gene_Id":"114004396", "Aliases":"long noncoding RNA activated by TGF-beta", "Reason":"lncRNA-ATB enhanced the expression of ZEB1 and ZEB2 by competitive binding to the miR-200 family and hence,induced EMT and invasion. Furthermore, lncRNA-ATB stimulated organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signalling. Generally, lncRNA_x0002_ATB promotes the invasion-metastases cascade.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"24768205", "fId":43, "NONCODEId":"NONHSAG068618.1"},
 {"ID":"EL000044", "Name":"JPX", "NCBI_gene_Id":"554203", "Aliases":"JPX transcript, XIST activator;DCBALD06, ENOX, LINC00183, NCRNA00183", "Reason":"Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"JPX is a nonprotein-coding RNA transcribed from a gene within the X-inactivation center (XIC; MIM 314670) that appears to participate in X chromosome inactivation", "PMID":"30556851", "fId":44, "NONCODEId":"NONHSAG054791.3"},
 {"ID":"EL000046", "Name":"KCNQ1OT1", "NCBI_gene_Id":"10984", "Aliases":"KCNQ1 opposite strand/antisense transcript 1;KCNQ1-AS2, KCNQ10T1, Kncq1, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012", "Reason":"KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"Human chromosomal region 11p15.5 contains two clusters of epigenetically-regulated genes that are expressed from only one chromosome in a parent-of-origin manner. Each cluster, or imprinted domain, is regulated by a functionally independent imprinting control region (ICR). The human CDKN1C/KCNQ1OT1 domain is regulated by an ICR located in an intron of KCNQ1, and contains at least eight genes that are expressed exclusively or preferentially from the maternally-inherited allele. The DNA of the ICR is specifically methylated on the maternally-inherited chromosome, and unmethylated on the paternally-inherited chromosome. The ICR contains the promoter of the KCNQ1OT1 gene that is exclusively expressed from the paternal allele. The KCNQ1OT1 transcript is the antisense to the KCNQ1 gene and is a unspliced long non-coding RNA. It interacts with chromatin and regulates transcription of multiple target genes through epigenetic modifications. The transcript is abnormally expressed from both chromosomes in most patients with Beckwith-Wiedemann syndrome, and the transcript also plays an important role in colorectal carcinogenesis.", "PMID":"31909901", "fId":46, "NONCODEId":"NONHSAG007431.3"},
 {"ID":"EL000049", "Name":"FLVCR1-DT", "NCBI_gene_Id":"642946", "Aliases":"FLVCR1 divergent transcript;LQK1; FLVCR1-AS1; NCRNA00292", "Reason":"LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma. FLVCR1-AS1 knockdown  remarkably inhibited HCC cell proliferation, migration, and invasion in vitro and in vivo while induced cell apoptosis.In mechanism, FLVCR1-AS1 acted as a microRNA sponge of miR-513c which targeted the mRNA of MET for degradation. By directly sponging miR-513c, FLVCR1-AS1 increased MET expression in HCC and then promoted HCC growth.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29574975", "fId":49, "NONCODEId":"NONHSAG004247.3"},
 {"ID":"EL000052", "Name":"DLX6-AS1", "NCBI_gene_Id":"285987", "Aliases":"DLX6 antisense RNA 1;Evf-2; DLX6AS; DLX6-AS; NCRNA00212", "Reason":"DLX6-AS1 was significantly upregulated in PCa(Prostate cancer) tissues and cells.Knockdown of DLX6-AS1 inhibited PCa progression by suppressing cell proliferation and accelerating cell apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"Predicted to act upstream of or within positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.", "PMID":"33035382", "fId":52, "NONCODEId":"NONHSAG048270.3"},
 {"ID":"EL000053", "Name":"NORAD", "NCBI_gene_Id":"647979", "Aliases":"non-coding RNA activated by DNA damage;LINC00657", "Reason":"LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"33309645", "fId":53, "NONCODEId":"NONHSAG031696.3"},
 {"ID":"EL000055", "Name":"PANDAR", "NCBI_gene_Id":"101154753", "Aliases":"promoter of CDKN1A antisense DNA damage activated RNA;PANDA", "Reason":"Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a non-coding RNA that is thought to regulate the response to DNA damage. This gene is induced by tumor protein p53 and interacts with and modulates the activity of a transcription factor that induce pro-apoptotic genes. Deregulation of this gene is associated with cancer progression.", "PMID":"31104011", "fId":55, "NONCODEId":"NONHSAG094129.1"},
 {"ID":"EL000056", "Name":"BACE1-AS", "NCBI_gene_Id":"100379571", "Aliases":"BACE1 antisense RNA;BACE1-AS1, BACE1AS, NCRNA00177", "Reason":"The BACE1-antisense transcript (BACE1-AS) regulates BACE1 mRNA and subsequently BACE1 protein expression in vitro and in vivo.  this conserved noncoding antisense transcript for \u03b2-secretase-1 (BACE1) is a crucial enzyme in Alzheimer\u2019s disease pathophysiology.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene encodes an unspliced long non-coding RNA transcribed from the opposite strand to BACE1. The encoded transcript is thought to form an RNA duplex with BACE1 mRNA thereby regulating its expression and is also thought to promote post-transcriptional feed-forward regulation of BACE1. This may lead to increased levels of beta amyloid and increased senile plaque deposition, and therefore may play a role in the pathophysiology of Alzheimer's disease.", "PMID":"33667514", "fId":56, "NONCODEId":"NONHSAG009728.2"},
 {"ID":"EL000057", "Name":"ATXN8OS", "NCBI_gene_Id":"6315", "Aliases":"ATXN8 opposite strand lncRNA;SCA8; KLHL1AS; NCRNA00003", "Reason":"Knockdown of ATXN8OS inhibited proliferation, viability and invasion in the human MCF7 and MDA-MB-231 BC cell lines.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is an antisense transcript to the KLHL1 gene (homolog to the Drosophila KELCH gene); it does not itself appear to be protein coding. A TAC/TGC trinucleotide repeat expansion that is incorporated into this gene transcript, but not the KLHL1 transcript, causes spinocerebellar ataxia type 8. Presumably the expansion interferes with normal antisense function of this transcript.", "PMID":"31173245", "fId":57, "NONCODEId":"NONHSAG013730.2"},
 {"ID":"EL000058", "Name":"UCA1", "NCBI_gene_Id":"652995", "Aliases":"urothelial cancer associated 1,CUDR, LINC00178, NCRNA00178, UCAT1, onco-lncRNA-36", "Reason":"The lncRNA UCA1 promotes proliferation,migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that was found to be upregulated in bladder cancer and plays a regulatory role in cell proliferation. This transcript regulates several genes, including CREB (cAMP responsive element binding protein). Expression of this transcript is regulated by CCAAT/enhancer-binding protein-alpha.", "PMID":"31272462", "fId":58, "NONCODEId":"NONHSAG025011.3"},
 {"ID":"EL000062", "Name":"HOTAIR", "NCBI_gene_Id":"100124700", "Aliases":"HOX transcript antisense RNA;HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072", "Reason":"In breast tumors,the expression of HOTAIR is significantly upregulated,HOTAIR overexpression augments cancer invasiveness and metastases and its depletion inhibits cancer invasiveness. siSENSE-mediated knockdown of HOTAIR suppressed the growth of MCF7 and eventually induced apoptotic cell death. HOTAIR is a proto-oncogene and may be misregulated upon exposure to endocrine disrupting chemicals (EDCs) such as BPA and DES and that may contribute toward disease progression including carcinogenesis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is located within the Homeobox C (HOXC) gene cluster on chromosome 12 and is co-expressed with the HOXC genes. It functions through an RNA product, which binds lysine specific demethylase 1 (LSD1) and Polycomb repressive complex 2 (PRC2), and serves as a scaffold to assemble these regulators at the HOXD gene cluster, thereby promoting epigenetic repression of HOXD. This gene is highly expressed in multiple tumors. Alternatively spliced transcript variants have been identified.", "PMID":"26208723", "fId":62, "NONCODEId":"NONHSAG011264.3"},
 {"ID":"EL000064", "Name":"FOXD3-AS1", "NCBI_gene_Id":"100996301", "Aliases":"FOXD3 antisense RNA 1 ;pasFOXD3", "Reason":"LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31541886", "fId":64, "NONCODEId":"NONHSAG001696.3"},
 {"ID":"EL000065", "Name":"NPSR1-AS1", "NCBI_gene_Id":"404744", "Aliases":"NPSR1 antisense RNA 1 ;AAA1", "Reason":"Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is located within a region that has been associated with asthma susceptibility. The locus is considered non-protein-coding based on lack of protein homology and a lack of experimental support for an encoded protein. Three alternatively spliced transcript variants have been identified for this gene.", "PMID":"33008585", "fId":65, "NONCODEId":"NONHSAG047319.2"},
 {"ID":"EL000066", "Name":"HOXA-AS3", "NCBI_gene_Id":"100133311", "Aliases":"HOXA cluster antisense RNA 3;HOXA6as", "Reason":"LncRNA HOXA-AS3 Sponges miR-29c to Facilitate Cell Proliferation, Metastasis, and EMT Process and Activate the MEK/ERK Signaling Pathway in Hepatocellular Carcinoma.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30963785", "fId":66, "NONCODEId":"NONHSAG096230.2"},
 {"ID":"EL000067", "Name":"MIR99AHG", "NCBI_gene_Id":"388815", "Aliases":"mir-99a-let-7c cluster host gene;MONC; C21orf34; C21orf35; LINC00478", "Reason":"LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.Knocking down DILA1 decreases Cyclin D1 protein expression, inhibits cancer cell growth and restores tamoxifen sensitivity both in vitro and in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"33139730", "fId":67, "NONCODEId":"NONHSAG083289.2"},
 {"ID":"EL000068", "Name":"E2F4", "NCBI_gene_Id":"1874", "Aliases":"E2F transcription factor 4;E2F-4", "Reason":"The knockdown of E2F4as in ovarian cancer cells led to a decrease in cell proliferation, invasion and migration and an increase in apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"33287341", "fId":68, "NONCODEId":"N.A."},
 {"ID":"EL000069", "Name":"ZEB2-AS1", "NCBI_gene_Id":"100303491", "Aliases":"ZEB2 antisense RNA 1;ZEB2AS; ZEB2-AS; ZEB2NAT", "Reason":"Knockdown of ZEB2-AS1 attenuated the proliferative, migratory and invasive abilities, but induced apoptosis of DLD1 and SW620 cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a spliced long non-coding RNA which is a natural antisense transcript corresponding to the 5' UTR of zinc finger E-box binding homeobox 2 (ZEB2). It is thought that this transcript may be involved in the regulation of ZEB2 expression, and may play a role in the progression of bladder cancer.", "PMID":"32277632", "fId":69, "NONCODEId":"NONHSAG029467.3"},
 {"ID":"EL000073", "Name":"LINC01426", "NCBI_gene_Id":"100506385", "Aliases":"long intergenic non-protein coding RNA 1426;lincRNA-uc002yug.2", "Reason":"In vitro assay revealed that knockdown of LINC01426 suppressed glioma cells proliferation, migration and invasion, and induced apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30338804", "fId":73, "NONCODEId":"NONHSAG082891.2"},
 {"ID":"EL000074", "Name":"MIR7-3HG", "NCBI_gene_Id":"284424", "Aliases":"MIR7-3 host gene;Huh7; PGSF1; C19orf30; LINC00306; NCRNA00306; uc002mbe.2", "Reason":"LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Knockdown of MIR7-3HG reduced the activity of Rb cells and increased the apoptosis of Rb cells, and vice versa.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32035086", "fId":74, "NONCODEId":"NONHSAG024540.3"},
 {"ID":"EL000075", "Name":"PCAT14", "NCBI_gene_Id":"101978785", "Aliases":"prostate cancer associated transcript 14", "Reason":"Long noncoding RNA PCAT-14 induces proliferation and invasion by  hepatocellular carcinoma cells by inducing methylation of miR-372.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"28415780", "fId":75, "NONCODEId":"NONHSAG083615.1"},
 {"ID":"EL000076", "Name":"PCAT6", "NCBI_gene_Id":"100506696", "Aliases":"prostate cancer associated transcript 6;PCAN-R1; KDM5BAS1; ncRNA-a2; KDM5B-AS1; onco-lncRNA-96", "Reason":"PCAT6 knockdown significantly inhibited cellular proliferation and metastasis, as well as induced early apoptosis of lung cancer cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"27458097", "fId":76, "NONCODEId":"NONHSAG003976.3"},
 {"ID":"EL000077", "Name":"HEIH", "NCBI_gene_Id":"100859930", "Aliases":"hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA ;HCCAT2; LINC-HEIH; LINC00848; lncRNA-HEIH", "Reason":"LncRNA-HEIH suppresses HCC cell growth and metastasis by up-regulating miR-199a-3p.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32572917", "fId":77, "NONCODEId":"NONHSAG042476.3"},
 {"ID":"EL000078", "Name":"MIR155HG", "NCBI_gene_Id":"114614", "Aliases":"MIR155 host gene;BIC; MIRHG2; miPEP155; NCRNA00172", "Reason":"the expression of MIR155HG was remarkably strong in PC tumor tissue and cell lines against adjacent normal tissue and cells. knockdown of MIR115HG strongly inhibited the cell proliferation, induced the cell cycle arrest, and further promoted the cell apoptosis in PC cells. The expression of miR-802 inhibitor partially reversed the knocking down effect of MIR115HG.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene represents a microRNA host gene. The long RNA transcribed from this gene is expressed at high levels in lymphoma and may function as an oncogene.", "PMID":"31161625", "fId":78, "NONCODEId":"NONHSAG032560.3"},
 {"ID":"EL000079", "Name":"MSC-AS1", "NCBI_gene_Id":"100132891", "Aliases":"MSC antisense RNA 1", "Reason":"MSC-AS1 was obviously upregulated in HCC tissues and HCC cells. Knockdown of MSC-AS1 repressed HepG2 and BEL-7404 cell proliferation, colony formation capacity, and triggered cell apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32489020", "fId":79, "NONCODEId":"NONHSAG050493.2"},
 {"ID":"EL000080", "Name":"EIF3J-DT", "NCBI_gene_Id":"645212", "Aliases":"EIF3J divergent transcript;EIF3J-AS1", "Reason":"H3K27 acetylation\u2010induced lncRNA EIF3J\u2010AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR\u20103163/YAP1 axis. The silence of EIF3J\u2010AS1 led to reduced proliferation and facilitated apoptosis of colorectal cancer cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31709617", "fId":80, "NONCODEId":"NONHSAG016741.3"},
 {"ID":"EL000081", "Name":"HOXA11-AS", "NCBI_gene_Id":"221883", "Aliases":"HOXA11 antisense RNA;HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076", "Reason":"Knockdown of HOXA11-AS inhibits Non\u2013small cell lung cancer cell proliferation and invasion.LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA in antisense to transcription of the homeobox A11 gene. This transcript may associate with chromatin factors such as Polycomb repressive complex and act as a sponge for microRNAs, thereby participating in the regulation of expression of target genes. High levels of this transcript may be associated with tumor progression.", "PMID":"29034803", "fId":81, "NONCODEId":"NONHSAG047191.3"},
 {"ID":"EL000083", "Name":"RBM5-AS1", "NCBI_gene_Id":"100775107", "Aliases":"RBM5 antisense RNA 1;LUST", "Reason":"LncRNA RBM5-AS1 was overexpressed in the Osteosarcoma(Os) tissues and cell lines. And lncRNA RBM5-AS1 promoted Os cell proliferation, migration, and invasion in vitro and tumor growth in vivo. knockdown of RBM5-AS1 significantly inhibited proliferation, migration, and invasion of Os cells in vitro as well as tumor growth in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a non-coding RNA in antisense to the RNA binding motif protein 5 (RBM5) gene. This transcript interacts with beta catenin and may regulate expression of WNT target genes.", "PMID":"33816613", "fId":83, "NONCODEId":"NONHSAG035103.2"},
 {"ID":"EL000084", "Name":"MIAT", "NCBI_gene_Id":"440823", "Aliases":"myocardial infarction associated transcript;RNCR2; GOMAFU; C22orf35; LINC00066; NCRNA00066; lncRNA-MIAT", "Reason":"Knocking down MIAT resulted in decreased cell proliferation, migration and invasion of cervical cancer cells, as well as suppression of tumor growth.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene encodes a spliced long non-coding RNA that may constitute a component of the nuclear matrix. Altered expression of this locus has been reported to be associated with a susceptibility to myocardial infarction. It has also been proposed that pathways involving this transcript may contribute to the pathophysiology of schizophrenia. A similar gene in mouse has been associated with retinal cell fate determination. Alternatively spliced transcript variants have been identified.", "PMID":"32239132", "fId":84, "NONCODEId":"NONHSAG033589.3"},
 {"ID":"EL000085", "Name":"FOXD2-AS1", "NCBI_gene_Id":"84793", "Aliases":"FOXD2 adjacent opposite strand RNA 1", "Reason":"Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axis. the inhibition of FOXD2-AS1 repressed HCC cell proliferation, enhanced cell apoptosis, and restrained cell invasion and migration. the knockdown of FOXD2-AS1 inhibited HCC progression by modulating the miR-206/MAP3K1 axis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32558350", "fId":85, "NONCODEId":"NONHSAG001375.3"},
 {"ID":"EL000086", "Name":"LINC00707", "NCBI_gene_Id":"100507127", "Aliases":"long intergenic non-protein coding RNA 707", "Reason":"Knockdown of LINC00707 expression significantly inhibited LoVo and HCT116 cell proliferation, migration, and invasion. LINC00707 acted as a molecular sponge by competing for miR-206 and indirectly modulating the expression of its targets, NOTCH3 and TM4SF1.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31213848", "fId":86, "NONCODEId":"NONHSAG005153.3"},
 {"ID":"EL000087", "Name":"PCAT7", "NCBI_gene_Id":"101928099", "Aliases":"prostate cancer associated transcript 7;PCAN-R2", "Reason":"PCAT7 Induces Poor Prognosis and Promotes Tumorigenesis by Inhibiting mir-134-5p in Non-Small-Cell Lung.Overexpression of PCAT7 resulted in the promotion of tumor cell proliferation, inhibition of cells apoptosis, facilitation of cells metastasis, and formation of EMT phenotype, while PCAT7 expression deletion remarkably prohibited cell proliferation, accelerated their apoptosis, weakened metastasis, and reversed EMT\uff08epithelial-to-mesenchymal transition to MET.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29275424", "fId":87, "NONCODEId":"NONHSAG052908.3"},
 {"ID":"EL000088", "Name":"CDKN2B-AS1", "NCBI_gene_Id":"100048912", "Aliases":"CDKN2B antisense RNA 1;ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089", "Reason":"Knockdown of long non-coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF-\u03b21 signaling pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is located within the CDKN2B-CDKN2A gene cluster at chromosome 9p21. The gene product is a functional RNA molecule that interacts with polycomb repressive complex-1 (PRC1) and -2 (PRC2), leading to epigenetic silencing of other genes in this cluster. This region is a significant genetic susceptibility locus for cardiovascular disease, and has also been linked to a number of other pathologies, including several cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma. Multiple alternatively processed transcript variants have been detected, some of which may take the form of circular RNA molecules", "PMID":"33325535", "fId":88, "NONCODEId":"NONHSAG101229.2"},
 {"ID":"EL000089", "Name":"ELFN1-AS1", "NCBI_gene_Id":"101927125", "Aliases":"ELFN1 antisense RNA 1 ;MYCLo-2", "Reason":"The lncRNA ELFN1-AS1 was significantly up-regulated in ESCA(esophageal cancer) tissues and cell lines when compared with the counterparts. Down-regulation of ELFN1-AS1 restrained cell proliferation, migration, and invasion of ESCA in vitro. lncRNA ELFN1-AS1 facilitates the progression of ESCA by acting as a competing endogenous RNA (ceRNA) to promote GFPT1 expression via sponging miR-183-3p.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32229685", "fId":89, "NONCODEId":"NONHSAG046781.3"},
 {"ID":"EL000090", "Name":"KTN1-AS1", "NCBI_gene_Id":"100129075", "Aliases":"KTN1 antisense RNA 1;MYCLo-3; C14orf33", "Reason":"KTN1-AS1 knockdown inhibited cell growth and proliferation, increased apoptosis, and modulated the expression of cell cycle- and apoptosis-related proteins (cyclin A1, cyclin-dependent kinase 2, Bcl2, and Bax) in NSCLC cell lines.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32820252", "fId":90, "NONCODEId":"NONHSAG015044.3"},
 {"ID":"EL000091", "Name":"SBF2-AS1", "NCBI_gene_Id":"283104", "Aliases":"SBF2 antisense RNA 1", "Reason":"knockdown of SBF2-AS1 significantly inhibited HCC(hepatocellular carcinoma) cells proliferation, migration and invasion.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30338801", "fId":91, "NONCODEId":"NONHSAG007631.2"},
 {"ID":"EL000092", "Name":"AFAP1-AS1", "NCBI_gene_Id":"84740", "Aliases":"AFAP1 antisense RNA 1;AFAP1AS; AFAP1-AS", "Reason":"In vitro experiments demonstrated that AFAP1-AS1 knockdown significantly inhibited the cell invasive and migration capability in lung cancer cells. AFAP1-AS1 knockdown also increased the expression of its antisense protein coding gene, actin filament associated protein 1(AFAP1), and affected the expression levels of several small GTPase family members and molecules in the actincytokeratin signaling pathway, which suggested that AFAP1-AS1 promoted cancer cell metastasis via regulation of actin filament integrity.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that is overexpressed in tumor cells and may promote cancer cell metastasis.", "PMID":"26245991", "fId":92, "NONCODEId":"NONHSAG037420.3"},
 {"ID":"EL000093", "Name":"HNF1A-AS1", "NCBI_gene_Id":"283460", "Aliases":"HNF1A antisense RNA 1;HAS1; C12orf27; NCRNA00262", "Reason":"knockdown of HNF1A-AS1 expression notably inhibited CRC\uff08 colorectal carcinoma\uff09 cell proliferation, migration, invasion and colony formation, and suppressed S-phase entry in vitro.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"28791380", "fId":93, "NONCODEId":"NONHSAG012534.3"},
 {"ID":"EL000094", "Name":"LPP-AS2", "NCBI_gene_Id":"339929", "Aliases":"LPP antisense RNA 2;MYCLo-5; MYCLo-6", "Reason":"Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop. LPP-AS2 depletion inhibited glioma cell proliferation, invasion and promoted apoptosis\nin vitro and restrained tumor growth in vivo, overexpression of LPP-AS2 resulted in the opposite effects.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32962742", "fId":94, "NONCODEId":"NONHSAG111667.1"},
 {"ID":"EL000095", "Name":"MNX1-AS1", "NCBI_gene_Id":"645249", "Aliases":"MNX1 antisense RNA 1;MAYA; CCAT5", "Reason":"Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.MNX1-AS1 was higher-expressed in osteosarcoma samples than that in adjacent tissues. The abilities of proliferation and invasion were suppressed after MNX1-AS1 was knocked down in vitro.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31364121", "fId":95, "NONCODEId":"NONHSAG049288.3"},
 {"ID":"EL000096", "Name":"TP73-AS1", "NCBI_gene_Id":"57212", "Aliases":"TP73 antisense RNA 1;PDAM; KIAA0495", "Reason":"TP73-AS1 could promote tumor growth and nvasion by acting as a ceRNA to promote GOLM1 expression by sponging miR-128-3p in PC pancreatic cancer).TP73-AS1 silencing inhibited PC cell proliferation, migration, and invasion in vitro as well as suppressed tumor growth in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"34007135", "fId":96, "NONCODEId":"NONHSAG000195.3"},
 {"ID":"EL000097", "Name":"LINC00473", "NCBI_gene_Id":"90632", "Aliases":"long intergenic non-protein coding RNA 473;LNC473; C6orf176; bA142J11.1", "Reason":"knockdown of LINC00473 resulted in the suppression of tumor cell proliferation, promotion of cells apoptosis, inhibition of cells metastasis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"involved_in transcription, DNA-templated", "PMID":"31081095", "fId":97, "NONCODEId":"NONHSAG045383.2"},
 {"ID":"EL000098", "Name":"LINC00673", "NCBI_gene_Id":"100499467", "Aliases":"long intergenic non-protein coding RNA 673;SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75", "Reason":"Linc00673 knockdown significantly inhibited cell proliferation and colony-forming ability, and suppressed S-phase entry in vitro and shRNA linc00673 mediated knockdown significantly inhibit tumor growth in vivo, meanwhile, linc00673 overexpression increased tumor cell growth. linc00673 could modulate the transcription of a large amount of genes including oncogene and tumor suppressor gene.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-protein coding RNA that is involved in the regulation of gene expression during tumor progression. This transcript can promote cell proliferation in gastric cancer through interaction with enhancer of zeste 2 and other epigenetic suppressors of gene expression, thereby downregulating target genes including Kruppel like factors 2 and 4. This transcript may also act as a tumor suppressor by promoting interaction between protein tyrosine phosphatase, non-receptor type 11 (Ptpn11) and ubiquitin ligase, resulting in degradation of Ptpn11 and lowered oncogenic signalling. Naturally-occurring variation at this locus results in the formation of a binding site for miR-1231, which negatively regulates activity of this transcript. Alternative splicing results in multiple transcript variants.", "PMID":"27027352", "fId":98, "NONCODEId":"NONHSAG022655.3"},
 {"ID":"EL000101", "Name":"NNT-AS1", "NCBI_gene_Id":"100652772", "Aliases":"NNT antisense RNA 1", "Reason":"NNT-AS1 facilitated proliferation, migration, invasion and EMT of NSCLC(non-small cell lung cancer) cells by sponging miR-22-3p and regulating YAP1 expression.NNT-AS1 knockdown impeded proliferation, migration, invasion and EMT of NSCLC cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31923353", "fId":101, "NONCODEId":"NONHSAG040320.3"},
 {"ID":"EL000102", "Name":"AGAP2-AS1", "NCBI_gene_Id":"100130776", "Aliases":"AGAP2 antisense RNA 1;PUNISHER", "Reason":"downregulation of AGAP2-AS1 depressed cell proliferation, migration, and invasion, and promoted cell apoptosis in GBM(glioblastoma multiforme). In summary, AGAP2-AS1 is a prognostic biomarker for patients with GBM, and functions as an oncogenic lncRNA to modulate GBM cell proliferation, apoptosis, migration, and invasion, which suggests that AGAP2-AS1 is potential therapeutic target for GBM.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"Biomarker of lung non-small cell carcinoma; malignant astrocytoma; and stomach cancer.", "PMID":"30525219", "fId":102, "NONCODEId":"NONHSAG064784.1"},
 {"ID":"EL000104", "Name":"FEZF1-AS1", "NCBI_gene_Id":"154860", "Aliases":"FEZF1 antisense RNA 1", "Reason":"the downregulation of FEZF1-AS1 expression significantly inhibited the CRC cells proliferation, migration and invasiveness, suppressed S-phase entry in vitro, and repressed tumor growth and metastasis in vivo. In contrast, overexpression of FEZF1-AS1 could promote the aggressive behaviors of CRC cells.FEZF1 knockdown also significantly suppressed CRC cell proliferation, migration, and invasion.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"26848625", "fId":104, "NONCODEId":"NONHSAG096627.2"},
 {"ID":"EL000105", "Name":"ZEBTR", "NCBI_gene_Id":"113391337", "Aliases":"ZEB1 transcriptional regulator RNA ;BX111", "Reason":"knockdown or overexpression of BX111 dramatically repressed or enhanced proliferation and invasion of pancreatic cancer cells.Mechanically, BX111 activated transcription of ZEB1, a key regulator for epithelia-mesenchymal transition (EMT), via recruiting transcriptional factor Y-box protein (YB1) to its promoter region. Moreover, we revealed that BX111 transcription was induced by hypoxia-inducible factor (HIF-1\u03b1) in response to hypoxia. In addition, BX111 contributed to the hypoxia-induced EMT of pancreatic cells by regulating expression of ZEB1 and its downstream proteins E-cadherin and MMP2. Coincidence with in vitro results, BX111 depletion effectively inhibited growth and metastasis of xenograft tumor in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29970904", "fId":105, "NONCODEId":"N.A."},
 {"ID":"EL000107", "Name":"PTCSC1", "NCBI_gene_Id":"100302522", "Aliases":"papillary thyroid carcinoma susceptibility candidate 1;PTCSC; NCRNA00197", "Reason":"AK023948 was substantially upregulated in tumor tissues. Meanwhile, higher AK023948 expression correlated with poor survival. Upregulation of AK023948 expression can promote HepG2 and Hep3B proliferation and invasion in in vitro experiments. Furthermore, AK023948 also decreased tumor growth in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29042961", "fId":107, "NONCODEId":"N.A."},
 {"ID":"EL000109", "Name":"CAMTA1-DT", "NCBI_gene_Id":"110841581", "Aliases":"CAMTA1 divergent transcript ;lncCAMTA1", "Reason":"The results showed that lncCAMTA1 expression promoted cell viability and migration/invasion, while knockdown of lncCAMTA1 promoted cell apoptosis via binding with miR-20b. lncCAMTA1 negatively regulated miR-20b expression. VEGF was a target of miR-20b, leading to the modification of the phosphorylation levels of MAPK, ERK, JAK, STAT1, and STAT3. lncCAMTA1 might promote proliferation and mobility of human breast cancer cells via binding with miR-20b. VEGF was a direct target of miR-20b and regulated activation of the MAPK/ERK and JAK/STAT3 signaling pathways.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"28550685", "fId":109, "NONCODEId":"NONHSAG000253.3"},
 {"ID":"EL000111", "Name":"PACERR", "NCBI_gene_Id":"103752588", "Aliases":"PTGS2 antisense NFKB1 complex-mediated expression regulator RNA;PACER; PTGS2AS1; PTGS2-AS1", "Reason":"PACER was down-regulated and HOTAIR was up-regulated in OA. PACER overexpression may improve OA by inhibiting the apoptosis of chondrocyte through the down-regulation of lncRNA HOTAIR.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene represents transcription of a long non-coding RNA produced in antisense to the prostaglandin-endoperoxide synthase 2 (PTGS2) gene. This transcript interacts with NF-kB transcriptional regulators to promote expression of PTGS2.", "PMID":"31113870", "fId":111, "NONCODEId":"NONHSAG057043.2"},
 {"ID":"EL000113", "Name":"SPRY4\u2010IT1", "NCBI_gene_Id":"100642175", "Aliases":"SPRY4 intronic transcript 1 ;SPRIGHTLY", "Reason":"SPRY4-IT1 promotes proliferation and stemness of breast cancer cells as well as renewal ability and stemness maintenance of BCSCs by increasing the expression of TCF7L2 through targeting miR-6882-3p.SPRY4-IT1 overexpression promoted breast cancer cell proliferation and stemness in vitro and in vivo.SPRY4-IT1 knockdown suppressed BCSC(breast cancer stem cell) renewal ability and stemness maintenance in vivo and in vitro.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a non-coding RNA that is upregulated in several different tumors, including melanoma and breast and prostate cancer cells. This transcript may mediate cell growth, proliferation, and apoptosis. It regulates levels of lipin 2, and therefore may be involved in lipid biosynthesis. The primary transcript is cleaved to release a mature product that localizes to the cytoplasm (PMID:25344859). The full length structure of the primary and cleaved transcripts is unclear, and it is possible that the primary transcript is a splice variant of SPRY4 (sprouty RTK signaling antagonist 4).", "PMID":"31736268", "fId":113, "NONCODEId":"NONHSAG091284.1"},
 {"ID":"EL000116", "Name":"IATPR", "NCBI_gene_Id":"101929447", "Aliases":"ITGB1 adjacent tumor promoting lncRNA;linc-ITGB1; TCONS_00018476", "Reason":"linc-ITGB1 promotes breast cancer progression by inducing cell cycle arrest and interrupting the epithelial-to-mesenchymal transition process.The linc-ITGB1 knockdown with specific short hairpin RNA (shRNA) decreased cell proliferation and colony formation in vitro. Tumor growth in vivo was also inhibited by linc-ITGB1 depletion. In addition, linc-ITGB1 depletion caused cell accumulation in the G0/G1 phase.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"26601916", "fId":116, "NONCODEId":"N.A."},
 {"ID":"EL000117", "Name":"DLEU7-AS1", "NCBI_gene_Id":"100874074", "Aliases":"DLEU7 antisense RNA 1", "Reason":"The expression of DLEU7-AS1 is significantly increased in CRC, which is markedly associated with CRC staging, lymph node metastasis, distant metastasis and poor prognosis. DLEU7-AS1 may promote the proliferation, invasion and migration capacities of CRC through regulating the Wnt/\u03b2-catenin pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29364477", "fId":117, "NONCODEId":"NONHSAG013534.3"},
 {"ID":"EL000118", "Name":"ASAP1-IT1", "NCBI_gene_Id":"29065", "Aliases":"ASAP1 intronic transcript 1\uff1bASAP1IT; HSPC054; ASAP1-IT; ASAP1IT1; DDEF1IT1; NCRNA00050", "Reason":"the expression of ASAP1-IT1 is relatively upregulated in NSCLC cells and tissues, which can promote the proliferation, invasion and metastasis of NSCLC cells through regulating the PTEN/AKT signal pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29364481", "fId":118, "NONCODEId":"NONHSAG051291.2"},
 {"ID":"EL000119", "Name":"BANCR", "NCBI_gene_Id":"100885775", "Aliases":"BRAF-activated non-protein coding RNA;LINC00586", "Reason":"LncRNA BANCR is highly expressed in breast cancer, which is significantly correlated with the prognosis of patients; moreover, it can promote the growth, invasion and metastasis of ovarian cancer cells. The down-regulation of BANCR can inhibit the proliferation, invasion and metastasis capacities of MCF-7 cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that plays a role in tumor progression and epithelial to mesenchymal transition. This transcript acts through the MAP kinase signaling pathway.", "PMID":"29565494", "fId":119, "NONCODEId":"NONHSAG052510.2"},
 {"ID":"EL000120", "Name":"PCA3", "NCBI_gene_Id":"50652", "Aliases":"prostate cancer associated 3 ;DD3; PCAT3; NCRNA00019; PRUNE2-AS1", "Reason":"lncRNA PCA3 may coordinate EOC (epithelial ovarian carcinoma) tumorigenesis through disrupting miR-106b regulated gene expression.\u00a0siRNA\u00a0knockdown of PCA3 markedly inhibited\u00a0cell viability, induced\u00a0G1 phase arrest, and led to apoptosis in ovarian cancer cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a spliced, long non-coding RNA that is highly overexpressed in most types of prostate cancer cells and is used as a specific biomarker for this type of cancer. This gene is embedded in an intronic region of the prune2 gene on the opposite DNA strand. The transcript regulates prune2 levels through formation of a double-stranded RNA that undergoes adenosine deaminase acting on RNA-dependent adenosine-to-inosine RNA editing. In prostate cancer derived cells, overexpression of PCA induced downregulation of prune2, leading to decreased cell proliferation. Conversely, silencing in prostate cancer cells resulted in increased proliferation. Regulation of this gene appears to be sensitive to androgen-receptor activation, a molecular signature of prostate cancer. Alternative splicing results in multiple transcript variants.", "PMID":"28864116", "fId":120, "NONCODEId":"NONHSAG052609.2"},
 {"ID":"EL000121", "Name":"SChLAP1", "NCBI_gene_Id":"101669767", "Aliases":"SWI/SNF complex antagonist associated with prostate cancer 1;PCAT11; PCAT114; LINC00913", "Reason":"SChLAP1 was overexpressed in bladder cancer tissues compared to paired normal bladder tissues. Cell growth arrest, apoptosis induction and migration inhibition were also observed in bladder cancer T24 and 5637 cells after transfection with SChLAP1 siRNA.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"26861061", "fId":121, "NONCODEId":"NONHSAG029985.2"},
 {"ID":"EL000122", "Name":"SNHG20", "NCBI_gene_Id":"654434", "Aliases":"small nucleolar RNA host gene 20;C17orf86; LINC00338; NCRNA00338; SCARNA16HG", "Reason":"SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30780105", "fId":122, "NONCODEId":"NONHSAG022845.2"},
 {"ID":"EL000123", "Name":"GAPLINC", "NCBI_gene_Id":"100505592", "Aliases":"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA;LINC01540", "Reason":"GAPLINC expression was significantly up-regulated in both GBM tissues and cell lines. The overexpression of GAPLINC was associated with shorter overall survival and disease-free survival. Functional assays indicated that GAPLINC silencing suppressed GBM cells proliferation, migration, and invasion, and promoted apoptosis. In the mechanism,GAPLINC acted as a competing endogenous RNA to sponge miR-331-3p and knockdown of GAPLINC promoted the expression of miR-331-3p.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30657584", "fId":123, "NONCODEId":"NONHSAG075363.2"},
 {"ID":"EL000124", "Name":"BLACAT1", "NCBI_gene_Id":"101669762", "Aliases":"bladder cancer associated transcript 1;LINC00912; linc-UBC1; onco-lncRNA-30", "Reason":"Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31174090", "fId":124, "NONCODEId":"NONHSAG004054.2"},
 {"ID":"EL000125", "Name":"DLEU2", "NCBI_gene_Id":"8847", "Aliases":"deleted in lymphocytic leukemia 2 ;ALT1; DLB2; LEU2; RFP2; BCMSUN; RFP2OS; MIR15AHG; TRIM13OS; LINC00022; NCRNA00022", "Reason":"The expression of long non-coding RNA (lncRNA) DLEU2 was observably high in GC cells and tissues. DLEU2 silence depressed the capacities of proliferation, migration and invasion but promoted apoptosis in GC cells. Moreover, DLEU2 was activated by signal transducer and activator of transcription 1 (STAT1) and sequestered microRNA-23b-3p (miR-23b-3p) to modulate the expression of notch receptor 2 (NOTCH2), thereby stimulating Notch signaling pathway. More importantly, DLEU2 contributed to GC progression via targeting miR-23b-3p/NOTCH2 axis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This locus represents a microRNA host gene and also produces long alternatively spliced non-coding RNAs. This genome region was observed to be deleted or epigenetically suppressed in leukemia, and was implicated as a negative regulator of cell proliferation. However, an alternative transcript produced at this locus was also found to promote progression through the cell cycle via angiotensin I converting enzyme 2 and cyclin D1.", "PMID":"33785336", "fId":125, "NONCODEId":"NONHSAG013515.3"},
 {"ID":"EL000126", "Name":"SOX2-OT", "NCBI_gene_Id":"347689", "Aliases":"SOX2 overlapping transcript;SOX2OT; NCRNA00043", "Reason":"Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/\u03b2-Catenin Pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces alternatively spliced long non-coding RNAs. These RNAs were observed to be upregulated in tumor cells and positively correlated to expression of the SRY-box 2 gene. Overexpression of these transcripts may promote cell proliferation.", "PMID":"32407168", "fId":126, "NONCODEId":"NONHSAG036783.3"},
 {"ID":"EL000128", "Name":"LUCAT1", "NCBI_gene_Id":"100505994", "Aliases":"lung cancer associated transcript 1 ;SCAL1; SCAT5", "Reason":"LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.lncRNA LUCAT1 knockdown dramatically suppressed PDAC cell proliferation, induced cell cycle arrest and inhibited cell migration and invasion.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31789465", "fId":128, "NONCODEId":"NONHSAG041002.3"},
 {"ID":"EL000131", "Name":"LINC00857", "NCBI_gene_Id":"439990", "Aliases":"long intergenic non-protein coding RNA 857;HUMT", "Reason":"knockdown of LINC00857 with siRNAs decreased tumor cell proliferation, colony formation, migration and invasion in vitro, as well as tumor growth in vivo. Overexpression of LINC00857 increased cancer cell proliferation, colony formation and invasion. Mechanistic analyses indicated that LINC00857 mediates tumor progression via cell cycle regulation.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"26862852", "fId":131, "NONCODEId":"NONHSAG006362.2"},
 {"ID":"EL000133", "Name":"LUNAR1", "NCBI_gene_Id":"104564224", "Aliases":"leukemia-associated non-coding IGF1R activator RNA 1", "Reason":"LUNAR1 knockdown significantly repressed cell proliferation of DLBCL by regulating E2F1, cyclin D1 and p21.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is thought to produce a functional long non-coding RNA. It is regulated by Notch and is overexpressed in T cell acute lymphoblastic leukemia. The transcript acts as a positive regulator of cell division by promoting expression of the insulin-like growth factor type I receptor (IGF1R) gene.", "PMID":"26796267", "fId":133, "NONCODEId":"NONHSAG018058.2"},
 {"ID":"EL000134", "Name":"HOTAIRM1", "NCBI_gene_Id":"100506311", "Aliases":"HOXA transcript antisense RNA, myeloid-specific 1;HOXA-AS1; HOXA1-AS1; NCRNA00179", "Reason":"The silencing of HOTAIRM1 significantly impairs the proliferation, apoptosis, self-renewal, tumorigenesis of GSCs(glioma stem cells ).", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This non-coding locus is located in the HOX gene cluster. Transcription of this locus is induced by retinoic acid, and transcripts likely function in regulation of myelopoiesis through transcriptional activation of several genes in the HOXA cluster, in addition to several beta-2 integrins.", "PMID":"31691127", "fId":134, "NONCODEId":"NONHSAG096227.2"},
 {"ID":"EL000137", "Name":"CEBPA-DT", "NCBI_gene_Id":"80054", "Aliases":"CEBPA divergent transcript ;ADINR; CEBPA-AS1", "Reason":"Silence of CEBPA-AS1 inhibited OSCC(Oral squamous cell carcinoma)cells proliferation and induced cells apoptosis, migration and invasion by targeting CEBPA and via a novel pathway CEBPA/Bcl2.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29281558", "fId":137, "NONCODEId":"N.A."},
 {"ID":"EL000138", "Name":"INHBA-AS1", "NCBI_gene_Id":"285954", "Aliases":"INHBA antisense RNA 1", "Reason":"NHBA-AS1 downregulation in CRC(colorectal cancer )cells suppressed CRC cell proliferation as well as colony formability. LncRNA INHBA-AS1 promotes colorectal cancer cell proliferation by sponging miR-422a to increase AKT1 axis", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"33090398", "fId":138, "NONCODEId":"NONHSAG047433.3"},
 {"ID":"EL000139", "Name":"MIR4435-2HG", "NCBI_gene_Id":"541471", "Aliases":"MIR4435-2 host gene ;AGD2; MORRBID; LINC00978; MIR4435-1HG; lncRNA-AWPPH", "Reason":"MIR4435-1HG knockdown inhibited cell proliferation, and suppressed the migrating and invasive capacity of renal carcinoma cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32538823", "fId":139, "NONCODEId":"NONHSAG056025.3"},
 {"ID":"EL000140", "Name":"THORLNC", "NCBI_gene_Id":"100506797", "Aliases":"testis associated oncogenic lncRNA;THOR", "Reason":"THOR could promote HCC cell growth and metastasis by amplifying PTEN/AKT signaling.THOR depletion resulted in significant inhibition of the growth and metastasis of HCC cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30098425", "fId":140, "NONCODEId":"N.A."},
 {"ID":"EL000141", "Name":"DANCR", "NCBI_gene_Id":"57291", "Aliases":"differentiation antagonizing non-protein coding RNA;AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR", "Reason":"the knockdown of lncRNA DANCR inhibited cell proliferation and autophagy of HCC cells. lncRNA DANCR induced cell proliferation, colony formation and autophagy by increasing ATG7 and suppressing miR-222-3p.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that functions as a negative regulator of cell differentiation. This transcript associates with enhancer of zeste homolog 2 to repress expression of the runt related transcription factor 2 gene. Increased expression of this transcript may be associated with cancer. Alternatively spliced transcript variants have been observed.", "PMID":"32964966", "fId":141, "NONCODEId":"NONHSAG037936.3"},
 {"ID":"EL000142", "Name":"PCGEM1", "NCBI_gene_Id":"64002", "Aliases":"PCGEM1 prostate-specific transcript;PCAT9; LINC00071; NCRNA00071", "Reason":"LncRNA PCGEM1 was upregulated in glioma tissues and tumor cell lines. PCGEM1 upregulation predicted unsatisfactory prognosis. PCGEM1 knockdown inhibited proliferation, colony formation, migration and invasion. PCGEM1 knockdown delayed tumor growth in vivo. PCGEM1 played as a competing endogenous RNA (ceRNA) for miR-539-5p to promote CDK6 expression.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that is overexpressed in prostate cancer and may act a marker for tumor progression. This RNA may act a negative regulator of apoptosis, and may promote activity of androgen receptor and Myc.", "PMID":"33589577", "fId":142, "NONCODEId":"NONHSAG030129.3"},
 {"ID":"EL000144", "Name":"LINC00525", "NCBI_gene_Id":"84847", "Aliases":"long intergenic non-protein coding RNA 525", "Reason":"LINC00525 expression was significantly upregualted in NSCLC(non-small cell lung cancer) tissues and cell lines, and correlated with poor prognosis. LINC00525 depletion inhibited the proliferation, migration and invasion in NSCLC cell line A549 and SPC-A1 cells. In vivo study further confirmed that LINC00525 knockdown inhibited tumor growth in nude model. Mechanically, LINC00525 served as a molecular sponge for miR-338-3p, and modulated expression of endogenous miR-338-3p-targeted insulin receptor substrate 2(IRS2).", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31991382", "fId":144, "NONCODEId":"NONHSAG047544.3"},
 {"ID":"EL000145", "Name":"CRNDE", "NCBI_gene_Id":"643911", "Aliases":"colorectal neoplasia differentially expressed;CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180", "Reason":"Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.knockdown of CRNDE significantly inhibited NSCLC(non-small cell lung cancer) cell proliferation, colony formation, migration and invasionin vitro, and decreased the xenograft tumor volume and weight in vitro.miR-338-3p is a downstream target of CRNDE and that miR-338-3p inhibition partially reversed the CRNDE depletion-mediated inhibitory effect on cell proliferation, colony formation, migration and invasion in NSCLC cells.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene is transcribed into multiple transcript variants, some of which may function as non-coding RNAs. One of the transcript variants encodes a putative short protein that is localized to the nucleus (PMID:25978564). Expression of this locus is increased in proliferating tissues, including certain tumors such as colorectal adenomas and adenocarcinomas. Transcription from this gene is negatively regulated by insulin and insulin-like growth factors, and may regulate the expression of genes involved in metabolism.", "PMID":"30554121", "fId":145, "NONCODEId":"NONHSAG072176.2"},
 {"ID":"EL000146", "Name":"CASC15", "NCBI_gene_Id":"401237", "Aliases":"cancer susceptibility 15;CANT; LINC00340; lnc-SOX4-1", "Reason":"CASC15 expression was remarkably upregulated in NSCLC samples compared with that in adjacent samples. Cell proliferation, invasion, and migration in NSCLC(non-small cell lung cancer) were inhibited via knockdown of CASC15 in vitro. Moreover, RT-qPCR results revealed that miR-130b-3p was upregulated via knockdown of CASC15 in vitro. In addition, miR-130b-3p was a direct target of CASC15 in NSCLC. Tumor formation and metastasis were inhibited after CASC15 was knockdown in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that may regulate cell proliferation. This RNA is upregulated in hepatocellular carcinoma, where it is thought to function as an oncogene. However, some splice variants of this gene may function as a tumor suppressor in neuroblastoma and other tumor types. Circular RNA variants were observed at this gene.", "PMID":"31599419", "fId":146, "NONCODEId":"NONHSAG056029.3"},
 {"ID":"EL000147", "Name":"HOXA-AS2", "NCBI_gene_Id":"285943", "Aliases":"HOXA cluster antisense RNA 2;HOXA3as", "Reason":"LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.HOXA-AS2 depletion obviously influenced cell proliferation, migration, invasion, as well as epithelial-to-mesenchymal transition (EMT) progression.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that promotes cell proliferation. This transcript may interact with enhancer of zeste homolog 2 Polycomb repressive complex to repress gene expression.", "PMID":"32519740", "fId":147, "NONCODEId":"NONHSAG047182.2"},
 {"ID":"EL000148", "Name":"SNHG6", "NCBI_gene_Id":"641638", "Aliases":"small nucleolar RNA host gene 6;U87HG; HBII-276HG; NCRNA00058", "Reason":"SNHG6 promoted EMT and BC cell proliferation and migration by acting as a miR-543 sponge and disinhibiting LAMC1/PI3K/AKT pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"33782812", "fId":148, "NONCODEId":"NONHSAG050423.2"},
 {"ID":"EL000149", "Name":"LncARSR", "NCBI_gene_Id":"102723932", "Aliases":"lncRNA regulator of Akt signaling associated with HCC and RCC ;lnc-TALC", "Reason":"lncARSR sponges miR\u201034a\u20105p to promote colorectal cancer invasion and metastasis via hexokinase\u20101\u2010mediated glycolysis.Functionally, ectopic expression of lncARSR promoted the invasion, metastasis, and glycolysis metabolic reprogramming of CRC cells in vitro and in vivo, while these activities were inhibited by silencing lncARSR expression.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32798250", "fId":149, "NONCODEId":"N.A."},
 {"ID":"EL000151", "Name":"LINC01551", "NCBI_gene_Id":"387978", "Aliases":"long intergenic non-protein coding RNA 1551;C14orf23; c14_5148", "Reason":"Inhibition of LINC01551 Impeded NPC Cell Proliferation and Metastasis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32329849", "fId":151, "NONCODEId":"NONHSAG014591.2"},
 {"ID":"EL000153", "Name":"GAS1RR", "NCBI_gene_Id":"100506834", "Aliases":"GAS1 adjacent regulatory RNA;LncRNA-Hh", "Reason":"The Shh-GLI1 pathway associated lncRNA-Hh, transcriptionally regulated by Twist, directly targets GAS1 to stimulate the activation of hedgehog signaling (Hh). The activated Hh increases GLI1 expression, and enhances the expression of SOX2 and OCT4 to play a regulatory role in CSC maintenance. Thus, the mammosphere-formation efficiency (MFE) and the self-renewal capacity in vitro, and oncogenicity in vivo in Twist-positive breast cancer cells are elevated. lncRNA-Hh silence in Twist-positive breast cells attenuates the activated Shh-GLI1 signaling and decreases the CSC-associated SOX and OCT4 levels, thus reduces the MFE and tumorigenesis of transplanted tumor.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"26418365", "fId":153, "NONCODEId":"NONHSAG052726.3"},
 {"ID":"EL000155", "Name":"SNHG1", "NCBI_gene_Id":"23642", "Aliases":"small nucleolar RNA host gene 1;UHG; U22HG; lncRNA16; LINC00057; NCRNA00057", "Reason":"High expression of lncRNA SNHG1 in prostate cancer patients and inhibition of SNHG1 suppresses cell proliferation and promotes apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This locus represents a small nucleolar RNA host gene that produces multiple alternatively spliced long non-coding RNAs. This gene is upregulated in cancers and is thought to act as promoter of cell proliferation. This transcript negatively regulates tumor suppressor genes such as tumor protein p53. Expression of this locus may be a marker of tumor progression.", "PMID":"33154308", "fId":155, "NONCODEId":"NONHSAG008552.3"},
 {"ID":"EL000156", "Name":"RHPN1-AS1", "NCBI_gene_Id":"78998", "Aliases":"RHPN1 antisense RNA 1;C8orf51", "Reason":"In vitro functional assays demonstrated that RHPN1-AS1 overexpression promoted SiHa cell proliferation, invasion and migration; while RHPN1-AS1 knockdown showed the opposite effects.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31525429", "fId":156, "NONCODEId":"NONHSAG114445.1"},
 {"ID":"EL000157", "Name":"EGFR-AS1", "NCBI_gene_Id":"100507500", "Aliases":"EGFR antisense RNA 1", "Reason":"EGFR-AS1 significantly up-regulated in GC tissues and correlated with tumor size. And the expression of EGFR-AS1 positively correlated with EGFR in tissues. Moreover, knock-down of EGFR-AS1 inhibited the proliferation of GC cells via suppressing EGFR-dependent PI3K/AKT pathway in vitro and in vivo. Mechanismly, depletion of EGFR-AS1 was found to decrease EGFR expression by reduction of EGFR mRNA stability.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30138934", "fId":157, "NONCODEId":"NONHSAG047620.3"},
 {"ID":"EL000158", "Name":"GHET1", "NCBI_gene_Id":"102723099", "Aliases":"gastric carcinoma proliferation enhancing transcript 1;lncRNA-GHET1", "Reason":"GHET1 was up-regulated in osteosarcoma tissues and cell lines, inhibited cell apoptosis, promoted cell proliferation, invasion and migration by affecting EMT in vitro, and was correlated with the tumor growth and metastasis in vivo.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene encodes an unspliced long non-coding RNA that has been suggested to promote the proliferation of gastric carcinoma cells and bladder cancer cells.", "PMID":"30475755", "fId":158, "NONCODEId":"NONHSAG113647.1"},
 {"ID":"EL000159", "Name":"LINC00461", "NCBI_gene_Id":"645323", "Aliases":"long intergenic non-protein coding RNA 461;VISC; NDIME; ECONEXIN; EyeLinc1", "Reason":"Knockdown of LINC00461 inhibits cell proliferation and induces apoptosis in gastric cancer by targeting LSD1.LINC00461 is upregulated in GC(gastric cancer), which is positively related to TNM staging and lymphatic metastasis. LINC00461 mediates proliferation and apoptosis of GC cells, thereafter aggravating the progression of GC.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This is an evolutionarily conserved gene that produces alternatively spliced long non-coding RNAs that may be expressed predominantly in the brain and visual cortex. These transcripts may be involved in tumorigenesis, as depletion by siRNA suppressed glioma cell division. Transcripts may also bind to and regulate the activity of miR-411-5p and argonaut 2, thereby altering the expression of genes involved in tumor growth.", "PMID":"31858544", "fId":159, "NONCODEId":"NONHSAG040969.3"},
 {"ID":"EL000160", "Name":"LINC00460", "NCBI_gene_Id":"728192", "Aliases":"long intergenic non-protein coding RNA 460", "Reason":"Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer.downregulation of LINC00460 promoted apoptosis of cell lines and was related to PI3K/AKT pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31364108", "fId":160, "NONCODEId":"NONHSAG014130.3"},
 {"ID":"EL000161", "Name":"ACTA2-AS1", "NCBI_gene_Id":"100132116", "Aliases":"ACTA2 antisense RNA 1;ZXF1; UC001kfo; uc001kfo.1", "Reason":"Knockdown of ACTA2-AS1 promotes liver cancer cell proliferation, migration and invasion.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"30664183", "fId":161, "NONCODEId":"NONHSAG006474.2"},
 {"ID":"EL000162", "Name":"MINCR", "NCBI_gene_Id":"100507316", "Aliases":"MYC-induced long non-coding RNA ;LINC01604", "Reason":"Long noncoding RNA MINCR regulates cellular proliferation, migration, and invasion in hepatocellular carcinoma.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"29550632", "fId":162, "NONCODEId":"NONHSAG051484.2"},
 {"ID":"EL000163", "Name":"TRPM2-AS", "NCBI_gene_Id":"101928607", "Aliases":"TRPM2 antisense RNA ;TRPM2-AS1", "Reason":"downregulation of TRPM2-AS inhibited the cell proliferation, migration, and invasion significantly (p < .05). TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31637708", "fId":163, "NONCODEId":"NONHSAG033027.3"},
 {"ID":"EL000164", "Name":"LSINCT5", "NCBI_gene_Id":"101234261", "Aliases":"long stress-induced non-coding transcript 5", "Reason":"Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31213092", "fId":164, "NONCODEId":"NONHSAG089950.1"},
 {"ID":"EL000165", "Name":"LINC01234", "NCBI_gene_Id":"100506465", "Aliases":"long intergenic non-protein coding RNA 1234;LCAL84; onco-lncRNA-32", "Reason":"LINC01234 knockdown suppressed cell proliferation, migration, and invasion of colorectal cancer cells, while blocked cell cycle and induced cell apoptosis.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31904146", "fId":165, "NONCODEId":"NONHSAG012367.2"},
 {"ID":"EL000166", "Name":"LINC-ROR", "NCBI_gene_Id":"100885779", "Aliases":"long intergenic non-protein coding RNA, regulator of reprogramming;ROR; lincRNA-RoR; lincRNA-ST8SIA3", "Reason":"LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"This gene produces a long non-coding RNA that regulates the reprogramming of pluripotent stem cells. This RNA suppresses induction of tumor protein p53 after DNA damage. It is thought to act as a sponge for microRNAs that regulate stem cell factors POU class 5 homeobox 1, Nanog, and SRY-box 2. This RNA may also have a extracellular role in modulating response to hypoxia in hepatocellular cancer cells. Expression of this transcript is associated with tumor progression and epithelial to mesenchymal transition and metastasis.", "PMID":"26898939", "fId":166, "NONCODEId":"NONHSAG023930.2"},
 {"ID":"EL000167", "Name":"DDX11-AS1", "NCBI_gene_Id":"100506660", "Aliases":"DDX11 antisense RNA 1;CONCR; SCAT4", "Reason":"Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis.knockdown of DDX11-AS1 repressed cell proliferation and clone formation, while induced cell cycle arrest and apoptosis. As expected, DDX11-AS1 overexpression displayed the opposite effect.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"32054332", "fId":167, "NONCODEId":"NONHSAG010798.3"},
 {"ID":"EL000168", "Name":"LINC00974", "NCBI_gene_Id":"147093", "Aliases":"long intergenic non-protein coding RNA 974", "Reason":"LncRNA LINC00974 Upregulates CDK6 to Promote Cell Cycle Progression in Gastric Carcinoma.", "Role":"Oncogene", "Organism":"Human", "Gene_Ontology_Annotations":"N.A.", "PMID":"31596614", "fId":168, "NONCODEId":"NONHSAG021780.2"}]